4d Molecular Therapeutics, INC. (FDMT) — DEF 14A Filings

All DEF 14A filings from 4d Molecular Therapeutics, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (2)

4D Molecular Therapeutics Files Definitive Proxy Statement — Apr 29, 2025 Risk: low
4D Molecular Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on April 29, 2025, for its annual meeting on June 17, 2025. The filing outlines t
4D Molecular Therapeutics Announces 2024 Annual Meeting of Stockholders — Apr 10, 2024 Risk: low
4D Molecular Therapeutics, Inc. (FDMT) filed a Proxy Statement (DEF 14A) with the SEC on April 10, 2024. The 2024 Annual Meeting of Stockholders for 4D Molecula

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX